Lilly takes patent fight to NAFTA; Claris to sell some infusion business rights;

@FiercePharma: KV says it's set to emerge from bankruptcy. News | Follow @FiercePharma

> Eli Lilly ($LLY) is taking its fight with Canada over the loss of its patent for its ADHD drug Strattera to a NAFTA tribunal. Story

> Fresenius Medical Care says plaintiffs who have sued the company in the U.S. for wrongful death related to its NaturaLyte and GranuFlo products are trying to get them consolidated. Story

> Indian drugmaker Claris has an agreement to sell some of its infusion business in India and emerging markets to two Japanese companies. Story

> The U.K.'s NICE drug cost watchdog has named a new chairman. Story

Medical Device News

 @FierceMedDev: AspenBio Pharma seeks rebirth as Venaxis, with focus on diagnostics. More | Follow @FierceMedDev

@MarkHFierce: A conservative Washington Post blogger calls out medical device tax "hypocrites" who voted for it, and now oppose it. Story | Follow @MarkHFierce

 @DamianFierce: Between FDA earfuls, analyst warnings and, now, a shareholder lawsuit, St. Jude Medical is having a rough winter. Article | Follow @DamianFierce

> Covidien gets Canadian nod for stroke-treating Solitaire. News

> Biocartis bags $44.5M Series D for molecular Dx commercialization. More

> St. Jude faces shareholder suit over Durata claims. Report

Biotech News

 @FierceBiotech: Eli Lilly hits the brakes on PhIII program in arthritis after 'unexpected' results. Story | Follow @FierceBiotech

@JohnCFierce: Who releases PhIII results one endpoint at a time? Stock up, but $ONCY PR is weak, manipulative. Count me skeptical. More | Follow @JohnCFierce

@RyanFierce: AZN missed big in Phase IIb for oral arthritis drug after previous mixed results. Should have killed program earlier? Report | Follow @RyanMFierce

> Ex-Genzyme CEO Termeer returns to his roots at biotech Prosensa. News

> The Medicines Co. bags Bristol, buyout deals for $300M. Article

Vaccine News

> GSK employs mobile phones to up vaccination rates in Africa. Report

> TB vaccine tested in infants of HIV-positive mothers. News

> IDRI fetches $10M from Gates Foundation for adjuvant research. Story

> GAVI Alliance aims to immunize 30 million girls against HPV. Item

> Global pediatric vaccine market to hit $23B by 2015. Article

Pharma Manufacturing News

> Court OKs drug shortage lawsuit against Hospira. News

> Manufacturing at the heart of Teva's $2B cost-cutting drive. Story

> 6 hospitalized as Novartis manufacturing stumbles again. Article

> Manufacturing at the heart of Teva's $2B cost-cutting drive. More

And Finally... Pfizer Consumer Healthcare on Wednesday introduced Robitussin CoughCast, a new interactive tool that allows people to track cough activity in their local area. Item

Suggested Articles

Merck is scouting replacements for CEO Ken Frazier with a preference toward an internal candidate, Bloomberg reports.

Bluebird Bio says the launch of Zynteglo, its first gene therapy, will not occur until 2020 while it tightens up its manufacturing processes.

Riival generics makers are squashing long-running lawsuits over their own versions of Sanofi's big-selling blood thinner Lovenox.